Thetradercentral has a report on dendreon, PRR gets a mention at the end.
"Dendreon’s success with Provenge comes as good news for global pharmaceutical giant Sanofi Aventis who have a similar first line product with “Taxotere”. Australian biotech Prima Biomed is also looking to enter the market with their own cvac product, the company has aspirations to list on the NASDAQ in the coming months"
http://www.thetradercentral.com/2011/05/dendreon/
another article in the usa about prr, page-39
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.005(1.69%) |
Mkt cap ! $436.3M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 31.0¢ | 29.0¢ | $504.5K | 1.673M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39998 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 3997 | 1 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |